Lazard Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.1M | Buy |
81,156
+21,982
| +37% | +$1.53M | 0.01% | 556 |
|
|
2025
Q4 | $3.93M | Buy |
59,174
+6,607
| +13% | +$427K | 0.01% | 625 |
|
|
2025
Q3 | $3.54M | Buy |
52,567
+8,999
| +21% | +$712K | ﹤0.01% | 683 |
|
|
2025
Q2 | $3.8M | Buy |
43,568
+464
| +1% | +$36.4K | 0.01% | 813 |
|
|
2025
Q1 | $2.94M | Sell |
43,104
-4,894
| -10% | -$399K | ﹤0.01% | 844 |
|
|
2024
Q4 | $3.73M | Buy |
47,998
+6,814
| +17% | +$504K | 0.01% | 711 |
|
|
2024
Q3 | $2.76M | Buy |
41,184
+7,761
| +23% | +$637K | ﹤0.01% | 794 |
|
|
2024
Q2 | $3.79M | Buy |
33,423
+1,000
| +3% | +$126K | ﹤0.01% | 744 |
|
|
2024
Q1 | $4.5M | Sell |
32,423
-14,582
| -31% | -$1.83M | 0.01% | 695 |
|
|
2023
Q4 | $5.83M | Buy |
47,005
+640
| +1% | +$65.4K | 0.01% | 652 |
|
|
2023
Q3 | $4.32M | Sell |
46,365
-828
| -2% | -$93.3K | 0.01% | 729 |
|
|
2023
Q2 | $6.06M | Buy |
47,193
+747
| +2% | +$90.3K | 0.01% | 671 |
|
|
2023
Q1 | $5.39M | Sell |
46,446
-31,357
| -40% | -$3.51M | 0.01% | 713 |
|
|
2022
Q4 | $8.81M | Sell |
77,803
-58,635
| -43% | -$6.44M | 0.01% | 600 |
|
|
2022
Q3 | $11M | Buy |
136,438
+327
| +0.2% | +$27.7K | 0.02% | 550 |
|
|
2022
Q2 | $10.1M | Buy |
136,111
+46,743
| +52% | +$4.27M | 0.01% | 582 |
|
|
2022
Q1 | $11.4M | Buy |
89,368
+15,628
| +21% | +$1.71M | 0.01% | 584 |
|
|
2021
Q4 | $9.9M | Buy |
73,740
+23,192
| +46% | +$3.33M | 0.01% | 631 |
|
|
2021
Q3 | $6.91M | Sell |
50,548
-6,452
| -11% | -$814K | 0.01% | 688 |
|
|
2021
Q2 | $6.08M | Buy |
57,000
+50,588
| +789% | +$4.86M | 0.01% | 698 |
|
|
2021
Q1 | $575K | Buy |
6,412
+1,756
| +38% | +$165K | ﹤0.01% | 963 |
|
|
2020
Q4 | $429K | Buy |
4,656
+448
| +11% | +$40K | ﹤0.01% | 1001 |
|
|
2020
Q3 | $433K | Hold |
4,208
| – | – | ﹤0.01% | 884 |
|
|
2020
Q2 | $426K | Buy |
4,208
+3,896
| +1,249% | +$349K | ﹤0.01% | 835 |
|
|
2020
Q1 | $21K | Buy |
+312
| New | +$19.4K | ﹤0.01% | 1425 |
|
|
2019
Q4 | – | Sell |
-14,048
| Closed | -$524K | – | 1559 |
|
|
2019
Q3 | $524K | Sell |
14,048
-8,172
| -37% | -$317K | ﹤0.01% | 819 |
|
|
2019
Q2 | $832K | Hold |
22,220
| – | – | ﹤0.01% | 879 |
|
|
2019
Q1 | $661K | Buy |
+22,220
| New | +$781K | ﹤0.01% | 889 |
|
|
2018
Q2 | – | Sell |
-56,804
| Closed | -$1.05M | – | 1045 |
|
|
2018
Q1 | $1.05M | Buy |
+56,804
| New | +$840K | ﹤0.01% | 713 |
|
|
2015
Q3 | – | Sell |
-3,600
| Closed | -$71K | – | 1096 |
|
|
2015
Q2 | $71K | Buy |
3,600
+340
| +10% | +$5.97K | ﹤0.01% | 945 |
|
|
2015
Q1 | $50K | Buy |
3,260
+2,900
| +806% | +$43.8K | ﹤0.01% | 972 |
|
|
2014
Q4 | $4K | Hold |
360
| – | – | ﹤0.01% | 1105 |
|
|
2014
Q3 | $3K | Buy |
+360
| New | +$3.68K | ﹤0.01% | 1017 |
|
Other funds holding DXCM
VCM
VPM
Lazard Asset Management's DXCM Position: Q1 2026 in Review
Lazard Asset Management increased its DexCom (DXCM) stake by 37% in Q1 2026, buying an estimated $1.53M and bringing the position to 81,156 shares worth $5.1M. The position accounts for 0.01% of the portfolio, ranked #556.
Lazard Asset Management first reported a position in DXCM in Q3 2014 and has held it in 33 quarters since. The position peaked at $11.4M in Q1 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Lazard Asset Management held 81,156 shares of DexCom worth $5.1M as of Q1 2026.
- Lazard Asset Management bought 21,982 DexCom shares in Q1 2026, an estimated $1.53M.
- DexCom made up 0.01% of Lazard Asset Management's portfolio in Q1 2026, its #556 holding.
- Lazard Asset Management first reported a position in DexCom in Q3 2014 and has held it in 33 quarters since.
- Lazard Asset Management's DexCom position peaked at $11.4M in Q1 2022.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.